Imaging Diagnostic Systems (IDS) gets investigational device exemption (IDE) for CT-M (computed tomography laser mammography):
This article was originally published in Clinica
Executive Summary
Imaging Diagnostic Systems (US) has received FDA permission to start a trial of its computed tomography laser mammography system. The IDS system uses a high power diode-pumped continuous visible laser to produce sharp, three-dimensional, cross-sectional images without the need for breast compression devices. The company predicts sales of $5 million this year in Europe, the Middle and Far East and US trial sites.